These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7562049)

  • 1. RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody.
    Philpott GW; Schwarz SW; Anderson CJ; Dehdashti F; Connett JM; Zinn KR; Meares CF; Cutler PD; Welch MJ; Siegel BA
    J Nucl Med; 1995 Oct; 36(10):1818-24. PubMed ID: 7562049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, biodistribution and dosimetry of copper-64-labeled anti-colorectal carcinoma monoclonal antibody fragments 1A3-F(ab')2.
    Anderson CJ; Schwarz SW; Connett JM; Cutler PD; Guo LW; Germain CJ; Philpott GW; Zinn KR; Greiner DP; Meares CF
    J Nucl Med; 1995 May; 36(5):850-8. PubMed ID: 7738663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper-64-labeled antibodies for PET imaging.
    Anderson CJ; Connett JM; Schwarz SW; Rocque PA; Guo LW; Philpott GW; Zinn KR; Meares CF; Welch MJ
    J Nucl Med; 1992 Sep; 33(9):1685-91. PubMed ID: 1517844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
    Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
    Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.
    Cutler PD; Schwarz SW; Anderson CJ; Connett JM; Welch MJ; Philpott GW; Siegel BA
    J Nucl Med; 1995 Dec; 36(12):2363-71. PubMed ID: 8523133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
    Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
    Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging recurrent metastatic colorectal carcinoma with PET.
    Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
    J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
    Gupta N; Bradfield H
    Semin Nucl Med; 1996 Jan; 26(1):65-73. PubMed ID: 8623053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.
    Inokuma T; Tamaki N; Torizuka T; Magata Y; Fujii M; Yonekura Y; Kajiyama T; Ohshio G; Imamura M; Konishi J
    Radiology; 1995 May; 195(2):345-52. PubMed ID: 7724751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
    Vitola JV; Delbeke D; Sandler MP; Campbell MG; Powers TA; Wright JK; Chapman WC; Pinson CW
    Am J Surg; 1996 Jan; 171(1):21-6. PubMed ID: 8554144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative PET imaging of experimental tumors with bromine-76-labeled antibodies, fluorine-18-fluorodeoxyglucose and carbon-11-methionine.
    Lövqvist A; Sundin A; Roberto A; Ahlström H; Carlsson J; Lundqvist H
    J Nucl Med; 1997 Jul; 38(7):1029-35. PubMed ID: 9225786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
    Gritters LS; Francis IR; Zasadny KR; Wahl RL
    J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
    Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
    J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
    Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E
    Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
    Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
    Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
    Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
    J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.